Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Iván del Moral-Sánchez & Kwinten Sliepen. (2019) Strategies for inducing effective neutralizing antibody responses against HIV-1. Expert Review of Vaccines 18:11, pages 1127-1143.
Read now
Read now
Jean-Louis Excler & Jerome H. Kim. (2019) Novel prime-boost vaccine strategies against HIV-1. Expert Review of Vaccines 18:8, pages 765-779.
Read now
Read now
Natalie A. Prow, Rocio Jimenez Martinez, John D. Hayball, Paul M. Howley & Andreas Suhrbier. (2018) Poxvirus-based vector systems and the potential for multi-valent and multi-pathogen vaccines. Expert Review of Vaccines 17:10, pages 925-934.
Read now
Read now
Articles from other publishers (23)
Venkata S. Bollimpelli, Pradeep B. J Reddy, Sailaja Gangadhara, Tysheena P. Charles, Samantha L. Burton, Gregory K. Tharp, Tiffany M. Styles, Celia C. Labranche, Justin C. Smith, Amit A. Upadhyay, Anusmita Sahoo, Traci Legere, Ayalnesh Shiferaw, Vijayakumar Velu, Tianwei Yu, Mark Tomai, John Vasilakos, Sudhir P. Kasturi, George M. Shaw, David Montefiori, Steven E. Bosinger, Pamela A. Kozlowski, Bali Pulendran, Cynthia A. Derdeyn, Eric Hunter & Rama R. Amara. (2023) Intradermal but not intramuscular modified vaccinia Ankara immunizations protect against intravaginal tier2 simian-human immunodeficiency virus challenges in female macaques. Nature Communications 14:1.
Crossref
Crossref
Lindsay J. Marshall, Jarrod Bailey, Manuela Cassotta, Kathrin Herrmann & Francesca Pistollato. (2023) Poor Translatability of Biomedical Research Using Animals — A Narrative Review. Alternatives to Laboratory Animals 51:2, pages 102-135.
Crossref
Crossref
Ros Chapman, Michiel van Diepen, Nicola Douglass, Shireen Galant, Mohamed Jaffer, Emmanuel Margolin, Phindile Ximba, Tandile Hermanus, Penny L. Moore & Anna-Lise Williamson. (2021) Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIV. Vaccines 9:11, pages 1281.
Crossref
Crossref
Chaojie Zhong, Fengliang Liu, Renee J. Hajnik, Lei Yao, Kangjing Chen, Meirong Wang, Yuejin Liang, Jiaren Sun, Lynn Soong, Wei Hou & Haitao Hu. (2021) Type I Interferon Promotes Humoral Immunity in Viral Vector Vaccination. Journal of Virology 95:22.
Crossref
Crossref
Sheikh Abdul Rahman, Bhrugu Yagnik, Alexander P. Bally, Kristen N. Morrow, Shelly Wang, Thomas H. VanderfordGordon J. Freeman, Rafi Ahmed & Rama Rao Amara. (2021)
PD-1 blockade and vaccination provide therapeutic benefit against SIV by inducing broad and functional CD8
+
T cells in lymphoid tissue
. Science Immunology 6:63.
Crossref
Crossref
Nanda Kishore Routhu, Narayanaiah Cheedarla, Sailaja Gangadhara, Venkata Satish Bollimpelli, Arun K. Boddapati, Ayalnesh Shiferaw, Sheikh Abdul Rahman, Anusmita Sahoo, Venkata Viswanadh Edara, Lilin Lai, Katharine Floyd, Shelly Wang, Stephanie Fischinger, Caroline Atyeo, Sally A. Shin, Sanjeev Gumber, Shannon Kirejczyk, Joyce Cohen, Sherrie M. Jean, Jennifer S. Wood, Fawn Connor-Stroud, Rachelle L. Stammen, Amit A. Upadhyay, Kathryn Pellegrini, David Montefiori, Pei-Yong Shi, Vineet D. Menachery, Galit Alter, Thomas H. Vanderford, Steven E. Bosinger, Mehul S. Suthar & Rama Rao Amara. (2021) A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs. Immunity 54:3, pages 542-556.e9.
Crossref
Crossref
Jesús Lavado-García, Irene González-Domínguez, Laura Cervera, Inmaculada Jorge, Jesús Vázquez & Francesc Gòdia. (2020) Molecular Characterization of the Coproduced Extracellular Vesicles in HEK293 during Virus-Like Particle Production. Journal of Proteome Research 19:11, pages 4516-4532.
Crossref
Crossref
Ziyu Wen & Caijun Sun. (2020) A Zigzag but Upward Way to Develop an HIV-1 Vaccine. Vaccines 8:3, pages 511.
Crossref
Crossref
Natalie A. Prow, Liang Liu, Mary K. McCarthy, Kevin Walters, Raj Kalkeri, Jillian Geiger, Fusataka Koide, Tamara H. Cooper, Preethi Eldi, Eri Nakayama, Kerrilyn R. Diener, Paul M. Howley, John D. Hayball, Thomas E. Morrison & Andreas Suhrbier. (2020) The vaccinia virus based Sementis Copenhagen Vector vaccine against Zika and chikungunya is immunogenic in non-human primates. npj Vaccines 5:1.
Crossref
Crossref
Zoe Moodie, Stephen R. Walsh, Fatima Laher, Lucas Maganga, Michael E. Herce, Sarita Naidoo, Mina C. Hosseinipour, Craig Innes, Linda-Gail Bekker, Nicole Grunenberg, Philipp Mann, Chenchen Yu, Allan C. deCamp, Maurine D. Miner, Nicole L. Yates, Jack Heptinstall, Nonhlanhla N. Mkhize, One Dintwe, Nicole Frahm, Kristen W. Cohen, Mary Allen, Julia Hutter, Ralf Wagner, Giuseppe Pantaleo, M. Juliana McElrath, Georgia D. Tomaras, Lynn Morris, David C. Montefiori, Erica Andersen-Nissen, Glenda E. Gray, Peter B. Gilbert & James G. Kublin. (2020) Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials. PLOS Medicine 17:5, pages e1003117.
Crossref
Crossref
Wenjin Fan, Yanmin Wan & Qingsheng Li. (2020) Interleukin-21 enhances the antibody avidity elicited by DNA prime and MVA boost vaccine. Cytokine 125, pages 154814.
Crossref
Crossref
Tiffany M. Styles, Sailaja Gangadhara, Pradeep B. J. Reddy, Sakeenah Hicks, Celia C. LaBranche, David C. Montefiori, Cynthia A. Derdeyn, Pamela A. Kozlowski, Vijayakumar Velu & Rama Rao Amara. (2019) Human Immunodeficiency Virus C.1086 Envelope gp140 Protein Boosts following DNA/Modified Vaccinia Virus Ankara Vaccination Fail To Enhance Heterologous Anti-V1V2 Antibody Response and Protection against Clade C Simian-Human Immunodeficiency Virus Challenge. Journal of Virology 93:20.
Crossref
Crossref
Laura Cervera, Francesc Gòdia, Ferran Tarrés-Freixas, Carmen Aguilar-Gurrieri, Jorge Carrillo, Julià Blanco & Sònia Gutiérrez-Granados. (2019) Production of HIV-1-based virus-like particles for vaccination: achievements and limits. Applied Microbiology and Biotechnology 103:18, pages 7367-7384.
Crossref
Crossref
Stephen J Kent & Miles P Davenport. (2019) Moving the HIV vaccine field forward: concepts of protective immunity. The Lancet HIV 6:6, pages e406-e410.
Crossref
Crossref
Samantha Burton, Lori M. Spicer, Tysheena P. Charles, Sailaja Gangadhara, Pradeep B. J. Reddy, Tiffany M. Styles, Vijayakumar Velu, Sudhir Pai Kasturi, Traci Legere, Eric Hunter, Bali Pulendran, Rama Amara, Peter Hraber & Cynthia A. Derdeyn. (2019) Clade C HIV-1 Envelope Vaccination Regimens Differ in Their Ability To Elicit Antibodies with Moderate Neutralization Breadth against Genetically Diverse Tier 2 HIV-1 Envelope Variants. Journal of Virology 93:7.
Crossref
Crossref
María Q. Marín, Patricia Pérez, Karl Ljungberg, Carlos Óscar S. Sorzano, Carmen E. Gómez, Peter Liljeström, Mariano Esteban & Juan García-Arriaza. (2019) Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV. Journal of Virology 93:7.
Crossref
Crossref
Alan D. CurtisIIIIKorey A. WalterRafiq NabiKara JensenAanini DwivediJustin PollaraGuido FerrariKoen K.A. Van RompayRama R. AmaraPamela A. KozlowskiKristina De Paris. (2019) Oral Coadministration of an Intramuscular DNA/Modified Vaccinia Ankara Vaccine for Simian Immunodeficiency Virus Is Associated with Better Control of Infection in Orally Exposed Infant Macaques. AIDS Research and Human Retroviruses 35:3, pages 310-325.
Crossref
Crossref
Andrew T. Jones, Xiaoying Shen, Korey L. Walter, Celia C. LaBranche, Linda S. Wyatt, Georgia D. Tomaras, David C. Montefiori, Bernard Moss, Dan H. Barouch, John D. Clements, Pamela A. Kozlowski, Raghavan Varadarajan & Rama Rao Amara. (2019) HIV-1 vaccination by needle-free oral injection induces strong mucosal immunity and protects against SHIV challenge. Nature Communications 10:1.
Crossref
Crossref
Masoud Foroutan, Fatemeh Ghaffarifar, Zohreh Sharifi, Abdolhosein Dalimi & Ogholniaz Jorjani. (2019)
Rhoptry antigens as
Toxoplasma gondii
vaccine target
. Clinical and Experimental Vaccine Research 8:1, pages 4.
Crossref
Crossref
Maria Pino, Mirko Paiardini & Vincent C. Marconi. (2018) Progress in achieving long-term HIV remission. Current Opinion in HIV and AIDS 13:5, pages 435-445.
Crossref
Crossref
Xintao HuAntonio ValentinYanhui CaiFrances DaytonMargherita RosatiEric G. Ramírez-SalazarViraj KulkarniKate E. BroderickNiranjan Y. SardesaiLinda S. WyattPatricia L. EarlBernard MossJames I. MullinsGeorge N. PavlakisBarbara K. Felber. (2018) DNA Vaccine–Induced Long-Lasting Cytotoxic T Cells Targeting Conserved Elements of Human Immunodeficiency Virus Gag Are Boosted Upon DNA or Recombinant Modified Vaccinia Ankara Vaccination. Human Gene Therapy 29:9, pages 1029-1043.
Crossref
Crossref
Vinoth K. Manoharan, Sunil K. Khattar, Celia C. LaBranche, David C. Montefiori & Siba K. Samal. (2018) Modified Newcastle Disease virus as an improved vaccine vector against Simian Immunodeficiency virus. Scientific Reports 8:1.
Crossref
Crossref
Eleni Panagioti, Paul Klenerman, Lian N. Lee, Sjoerd H. van der Burg & Ramon Arens. (2018) Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections. Frontiers in Immunology 9.
Crossref
Crossref